Phibro Animal Health | PAHC - Equity Capital And Reserves


Phibro Animal Health reported $361.83M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Align Technology USD 4.15B 100.27M Mar/2026
ANI Pharmaceuticals USD 562.3M 21.58M Mar/2026
Aurora Cannabis CAD 536.36M 30.74M Dec/2025
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Canopy Growth CAD 758.17M 22.16M Dec/2025
Corcept Therapeutics USD 637.99M 9.82M Mar/2026
Eli Lilly USD 31.2B 4.66B Mar/2026
Henry Schein USD 3.27B 21M Mar/2026
Idexx Laboratories USD 1.56B 49.28M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Merck USD 45.88B 6.73B Mar/2026
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Pacira USD 653.89M 39.22M Mar/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Prestige Brands USD 1.89B 58.06M Mar/2026
Supernus Pharmaceuticals USD 1.08B 15.09M Mar/2026
Zoetis USD 3.23B 98M Mar/2026